These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7817275)

  • 21. Prognostic factors of curatively resected esophageal carcinoma associated with multiple metastatic lymph nodes.
    Tabira Y; Sakaguchi T; Yoshida Y; Kuhara H; Kawasuji M
    Hepatogastroenterology; 2006; 53(71):715-9. PubMed ID: 17086875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness of postoperative radio- and chemotherapy in N(+) esophageal carcinoma].
    Sack H
    Strahlenther Onkol; 2002 Feb; 178(2):109-10. PubMed ID: 11942034
    [No Abstract]   [Full Text] [Related]  

  • 23. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, part 1.
    Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
    Oncology (Williston Park); 2005 May; 19(6):775-8, 783-4, 788 passim. PubMed ID: 15971452
    [No Abstract]   [Full Text] [Related]  

  • 24. [The latest problems of surgery for cancer of the esophagus].
    Nishihira T; Mori S; Sekine Y
    Rinsho Kyobu Geka; 1987; 7(5):419-24. PubMed ID: 9301793
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
    Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.
    Kato K; Hida Y; Miyamoto M; Hashida H; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H
    Cancer; 2002 Feb; 94(4):929-33. PubMed ID: 11920460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with RO-resected esophageal carcinoma].
    Mühlhöfer A; Kronawitter U; Zoller WG
    Z Gastroenterol; 1998 May; 36(5):479-81. PubMed ID: 9654711
    [No Abstract]   [Full Text] [Related]  

  • 28. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
    Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics of lymph node metastasis in thoracic esophageal carcinoma].
    Li JD; Wang WG; Xu JL; Gao ZR; Shao LF
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3197-200. PubMed ID: 17313786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
    Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM
    Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
    Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
    Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [History of combined modality therapy for esophageal cancer in Japan].
    Ando N; Kato H; Shinoda M; Fukuda H
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1674-7. PubMed ID: 20931728
    [No Abstract]   [Full Text] [Related]  

  • 33. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2.
    Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
    Oncology (Williston Park); 2005 Jun; 19(7):830, 835-6, 838 passim. PubMed ID: 16053033
    [No Abstract]   [Full Text] [Related]  

  • 34. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
    Wang Z; Liu XY; Liu FY
    Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Perioperative therapy in esophageal and stomach carcinoma].
    Stahl M; Wilke H; Meyer HJ
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():85-92. PubMed ID: 8692126
    [No Abstract]   [Full Text] [Related]  

  • 36. [The definitive radiochemotherapy in patients with T4 and/or M1 (lymph node) squamous-cell carcinoma of the esophagus].
    Mücke R; Fietkau R
    Strahlenther Onkol; 2000 Aug; 176(8):384-5. PubMed ID: 10987025
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
    Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus.
    Tsurumaru M; Kajiyama Y; Udagawa H; Akiyama H
    Ann Thorac Cardiovasc Surg; 2001 Dec; 7(6):325-9. PubMed ID: 11888470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical analysis of 33 cases of primary esophageal small cell carcinoma].
    Duan HB; Wu HY; Su XD; Zeng CG; Dai WQ; Huang L
    Ai Zheng; 2007 Jul; 26(7):771-4. PubMed ID: 17626757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Am J Clin Pathol; 2007 Dec; 128(6):1002-9. PubMed ID: 18024326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.